| 時間 | 主題 | ||||
|---|---|---|---|---|---|
PD02-1: Ferroptosis induction and glutathione peroxidase 4 suppression as mechanisms of Evodiamine's inhibition to high grade bladder cancer cell
講者:
胡哲源
座長:
吳俊德, 高建璋 |
胡哲源 |
吳俊德, 高建璋 |
|||
PD02-2: GDF15/prothymosin α signaling disruption as a potential therapy for muscle wasting in bladder cancer patients treated with cisplatin
講者:
胡哲源
座長:
吳俊德, 高建璋 |
胡哲源 |
吳俊德, 高建璋 |
|||
PD02-3: Urinary Exfoliated Cells as a Potential Biomarker for Urothelial Carcinoma
講者:
查舫宇
座長:
吳俊德, 高建璋 |
查舫宇 |
吳俊德, 高建璋 |
|||
PD02-4: The prognostic significance of CEBPD expression in patients with bladder urothelial carcinoma
講者:
李威明
座長:
吳俊德, 高建璋 |
李威明 |
吳俊德, 高建璋 |
|||
PD02-5: The farnesoid X receptor agonist GW4064 inhibits migration and invasion through β-catenin and MMP2 downregulation in human bladder cancer
講者:
高建璋
座長:
吳俊德, 高建璋 |
高建璋 |
吳俊德, 高建璋 |
|||
PD02-6: Comparison of the adverse events between 2 different BCG strains in patients receiving intravesical therapy for non-muscle invasive bladder urothelial carcinoma: A single center experience
講者:
張家郡
座長:
吳俊德, 高建璋 |
張家郡 |
吳俊德, 高建璋 |